Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Jul-23 6:19 AM View:  | Neurobo Pharmaceuticals, Inc. (NRBO) | 27-Jul-23 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 23-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 22-Jun-23 | Grant | 8,915 | -- | -- | 274% 3.26K to 12.17K | |
| 02-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 31-May-23 | Grant | 2,197 | -- | -- | 207% 1.06K to 3.26K | |
| 21-Jun-21 5:30 PM View: | Kala Bio, Inc. (KALA) | 17-Jun-21 | Grant | 25,000 | -- | -- | 89% 28.0K to 53.0K | |
| 29-Jun-20 9:36 PM View: | Kala Bio, Inc. (KALA) | 25-Jun-20 | Grant | 28,000 | -- | -- | 100% 0 to 28.0K | |
| 06-Jun-18 5:00 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 04-Jun-18 | Market Sale (Planned) | 156,573 | $0.37 | $58,589.60 | (12%) 1.34M to 1.18M | 92% |
| 16-May-18 7:50 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 14-May-18 | Market Sale (Planned) | 13,964 | $0.52 | $7,261.28 | (1%) 1.35M to 1.34M | 95% |
| 21-Mar-18 5:16 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 19-Mar-18 | Market Sale (Planned) | 9,739 | $1.70 | $16,556.30 | (< 1%) 1.36M to 1.35M | 98% |
| 06-Jun-17 8:28 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 05-Jun-17 | Market Sale | 161,906 | $1.28 | $207,110.00 | (11%) 1.53M to 1.36M | 98% |
| 12-May-17 9:52 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 109,190 | -- | -- | 8% 1.42M to 1.53M | |
| 22-Mar-17 4:17 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 20-Mar-17 | Market Sale (Planned) | 7,825 | $2.41 | $18,858.20 | (< 1%) 1.42M to 1.42M | 99% |
| 17-Mar-17 4:17 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 20,000 | $2.55 | $50,920.00 | 1% 1.4M to 1.42M | (99%) |
| 07-Jun-16 4:30 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 03-Jun-16 | Payment of Exercise | 206,070 | $3.97 | $818,098.00 | (13%) 1.61M to 1.4M | 99% |
| 13-May-16 4:30 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 12-May-16 | Market Purchase | 71,500 | $3.49 | $249,471.00 | 5% 1.54M to 1.61M | (99%) |
| 18-Mar-16 8:58 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 17-Mar-16 | Grant | 62,132 | -- | -- | 4% 1.48M to 1.54M | |
| 09-Feb-16 9:50 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 05-Feb-16 | Acquisition (other) | 1,476,670 | -- | -- | 100% 0 to 1.48M | |
| 04-Jun-15 6:38 PM View: | Pozen, Inc. (POZN) | 03-Jun-15 | Grant | 1,476,670 | -- | -- | 100% 0 to 1.48M | |
| 30-Jan-15 9:37 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jan-15 | Disposition (other) | 38,721 | $36.53 | $1,414,480.00 | (100%) 38.72K to 0 | (2%) |
| 24-Nov-14 4:56 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Nov-14 | Option Exercise | 134,375 | $19.95 | $2,680,310.00 | 305% 44.03K to 178.4K | |
| 24-Nov-14 4:56 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Nov-14 | Market Option Sale | 134,375 | $33.43 | $4,492,470.00 | (75%) 178.4K to 44.03K | (3%) |
| 24-Nov-14 4:56 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Nov-14 | Market Sale | 5,308 | $33.43 | $177,459.00 | (12%) 44.03K to 38.72K | (3%) |
| 20-Feb-14 5:37 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Grant | 22,675 | -- | -- | 103% 21.98K to 44.65K | |
| 20-Feb-14 5:37 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Payment of Exercise | 623 | $28.30 | $17,630.90 | (1%) 44.65K to 44.03K | (22%) |
| 11-Feb-14 9:40 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-14 | Payment of Exercise | 911 | $23.68 | $21,572.50 | (4%) 22.89K to 21.98K | (46%) |
| 25-Jun-13 4:02 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Jun-13 | Payment of Exercise | 102 | $17.15 | $1,749.30 | (< 1%) 22.99K to 22.89K | (101%) |
| 11-Feb-13 5:30 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Grant | 22,900 | -- | -- | 2290% 1.0K to 23.9K | |
| 11-Feb-13 5:30 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Payment of Exercise | 910 | $18.30 | $16,653.00 | (4%) 23.9K to 22.99K | (88%) |
| 25-Jun-12 5:02 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 21-Jun-12 | Grant | 1,000 | -- | -- | 100% 0 to 1.0K | |
| 16-May-11 6:11 PM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 142,779 | $5.00 | $713,895.00 | (100%) 142.78K to 0 | (< 1%) |
| 21-May-10 10:32 AM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 19-May-10 | Payment of Exercise | 107,221 | $6.04 | $647,615.00 | (43%) 250.0K to 142.78K | 4% |
| 21-May-10 10:32 AM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 19-May-10 | Option Exercise | 250,000 | -- | -- | 100% 0 to 250.0K | |
| 22-Oct-09 5:12 PM View: | Sepracor, Inc. (SEPR) | 20-Oct-09 | Disposition | 81,668 | $23.00 | $1,878,360.00 | (100%) 81.67K to 0 | < 1% |
| 19-Oct-09 5:21 PM View: | Sepracor, Inc. (SEPR) | 15-Oct-09 | Disposition (change in control) | 38,332 | $23.00 | $881,636.00 | (32%) 120.0K to 81.67K | < 1% |
| 14-May-09 9:47 PM View: | Sepracor, Inc. (SEPR) | 14-May-09 | Grant | 35,000 | $14.40 | $504,000.00 | 41% 85.0K to 120.0K | < 1% |
| 22-May-08 5:36 PM View: | Sepracor, Inc. (SEPR) | 20-May-08 | Grant | 55,000 | $21.26 | $1,169,300.00 | 183% 30.0K to 85.0K | (31%) |
| 12-Mar-07 8:32 PM View: | Sepracor, Inc. (SEPR) | 08-Mar-07 | Grant | 30,000 | $49.47 | $1,484,100.00 | 100% 0 to 30.0K | (71%) |
| 15-Dec-06 4:40 PM View: | Kos Pharmaceuticals Inc (KOSP) | 13-Dec-06 | Disposition (change in control) | 10,336 | $78.00 | $806,208.00 | (100%) 10.34K to 0 | |
| 30-Jan-06 8:23 PM View: | Kos Pharmaceuticals Inc (KOSP) | 26-Jan-06 | Grant | 10,000 | -- | -- | 3289% 0.3K to 10.3K | |
| 26-Jul-05 7:17 PM View: | Kos Pharmaceuticals Inc (KOSP) | 25-Jul-05 | Option Exercise | 10,000 | $27.09 | $270,900.00 | 3300% 0.3K to 10.3K | |
| 26-Jul-05 7:17 PM View: | Kos Pharmaceuticals Inc (KOSP) | 25-Jul-05 | Market Option Sale | 10,000 | $70.61 | $706,100.00 | (97%) 10.3K to 0.3K | |
| 10-May-05 6:11 PM View: | Kos Pharmaceuticals Inc (KOSP) | 09-May-05 | Option Exercise | 10,625 | $46.65 | $495,656.00 | 3507% 0.3K to 10.93K | |
| 10-May-05 6:11 PM View: | Kos Pharmaceuticals Inc (KOSP) | 09-May-05 | Market Option Sale | 10,625 | $53.14 | $564,612.00 | (97%) 10.93K to 0.3K | |
| 10-May-05 6:11 PM View: | Kos Pharmaceuticals Inc (KOSP) | 06-May-05 | Option Exercise | 10,000 | $27.09 | $270,900.00 | 3300% 0.3K to 10.3K | |
| 10-May-05 6:11 PM View: | Kos Pharmaceuticals Inc (KOSP) | 06-May-05 | Market Option Sale | 10,000 | $53.70 | $537,000.00 | (97%) 10.3K to 0.3K |